Single Cell Spatial Analysis Reveals the Topology of Immunomodulatory Purinergic Signaling in Glioblastoma | bioRxiv
![Recombinant Anti-Ezrin antibody [EP886Y] - Plasma Membrane Marker KO Tested (ab40839)](https://www.abcam.com/ps/products/40/ab40839/Images/ab40839-296576-anti-ezrin-antibody-ep886y-western-blot.jpg "Recombinant Anti-Ezrin antibody [EP886Y] - Plasma Membrane Marker KO Tested (ab40839)")
Recombinant Anti-Ezrin antibody [EP886Y] - Plasma Membrane Marker KO Tested (ab40839)
Downregulation of CD73 associates with T cell exhaustion in AML patients | Journal of Hematology & Oncology | Full Text
CD73 expression and activity in serum-derived exosomes. (A) A... | Download Scientific Diagram
Cancers | Free Full-Text | CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
IJMS | Free Full-Text | Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression
CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy | Nature Communications
Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer - ScienceDirect
B-hCD73 mice - Biocytogen
CD73 is downregulated on CD8 T cells in patients with newly diagnosed... | Download Scientific Diagram
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors | Nature Communications
Flow cytometric analysis of surface markers in normal and breast cancer... | Download Scientific Diagram
Evidence that cervical cancer cells cultured as tumorspheres maintain high CD73 expression and increase their protumor characteristics through TGF‐β production - García‐Rocha - 2022 - Cell Biochemistry and Function - Wiley Online Library
Biomarkers Testing for Bladder Cancer - Enzo Life Sciences
Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury | Journal of Nanobiotechnology | Full Text
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint | Nature Communications
Cancers | Free Full-Text | CD73, Tumor Plasticity and Immune Evasion in Solid Cancers
Frontiers | Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39 | Journal of Medicinal Chemistry
Frontiers | Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma
Macrophage diversity in cancer revisited in the era of single-cell omics: Trends in Immunology
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint | Nature Communications
Frontiers | Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
IJMS | Free Full-Text | Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
Novel insights based on the plasticity of T cells in the tumor microenvironment
Ecto‐5′‐nucleotidase (CD73) is a potential target of hepatocellular carcinoma - Shali - 2019 - Journal of Cellular Physiology - Wiley Online Library
Cancers | Free Full-Text | CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation | SpringerLink
